GSK-DB2113361

Study Sponsor: GSK

Study Title

A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 Inhalation Powder and the Individual Components Delivered Once-Daily via a Novel Dry Powder Inhaler in Subjects with Chronic Obstructive Pulmonary Disease

Medicine or Vaccine (generic name)

umeclidinium bromide/vilanterol

Sponsor Identification Number

DB2113361

Trial Registry Identification Number(#'s)

NCT01313637 2010-023348-33

Medical Condition

Pulmonary Disease, Chronic Obstructive

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=113361

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT01313637

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2010-023348-33

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

March 2014